Vertex Pharmaceuticals Inc (VRTX) stock
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3028% above fair value
$542.62−4.41 (-0.81%)
Close on Nov 12, 2026Market cap $137.53BP/E 31.6Yield –
Vertex Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Vertex Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was 35.0%. For fiscal 2025 it was 32.9%, against -4.9% the year before. The highest annual figure on record is 68.8% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 32.9% | +37.8 |
| FY2024 | Dec 31, 2024 | -4.9% | −41.5 |
| FY2023 | Dec 31, 2023 | 36.7% | −0.5 |
| FY2022 | Dec 31, 2022 | 37.2% | +6.3 |
| FY2021 | Dec 31, 2021 | 30.9% | −12.8 |
| FY2020 | Dec 31, 2020 | 43.7% | +15.4 |
| FY2019 | Dec 31, 2019 | 28.3% | −40.5 |
| FY2018 | Dec 31, 2018 | 68.8% | +58.2 |
| FY2017 | Dec 31, 2017 | 10.6% | +17.2 |
| FY2016 | Dec 31, 2016 | -6.6% | +47.3 |
| FY2015 | Dec 31, 2015 | -53.9% | +73.4 |
| FY2014 | Dec 31, 2014 | -127.2% | −90.5 |
| FY2013 | Dec 31, 2013 | -36.7% | −29.7 |
| FY2012 | Dec 31, 2012 | -7.0% | −9.1 |
| FY2011 | Dec 31, 2011 | 2.1% | +528.4 |
| FY2010 | Dec 31, 2010 | -526.3% | +103.9 |
| FY2009 | Dec 31, 2009 | -630.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 33.0% | −1.9 |
| Q1 FY2026 | Mar 31, 2026 | 34.5% | +11.2 |
| Q4 FY2025 | Dec 31, 2025 | 37.3% | +6.0 |
| Q3 FY2025 | Sep 30, 2025 | 35.2% | −2.5 |
| Q2 FY2025 | Jun 30, 2025 | 34.8% | +170.7 |
| Q1 FY2025 | Mar 31, 2025 | 23.3% | −17.5 |
| Q4 FY2024 | Dec 31, 2024 | 31.4% | −7.1 |
| Q3 FY2024 | Sep 30, 2024 | 37.7% | −4.0 |
| Q2 FY2024 | Jun 30, 2024 | -135.8% | −172.6 |
| Q1 FY2024 | Mar 31, 2024 | 40.9% | +11.4 |
| Q4 FY2023 | Dec 31, 2023 | 38.5% | +2.9 |
| Q3 FY2023 | Sep 30, 2023 | 41.7% | +1.8 |
| Q2 FY2023 | Jun 30, 2023 | 36.7% | −0.2 |
| Q1 FY2023 | Mar 31, 2023 | 29.5% | −6.9 |
| Q4 FY2022 | Dec 31, 2022 | 35.6% | −1.6 |
| Q3 FY2022 | Sep 30, 2022 | 39.9% | −3.1 |
| Q2 FY2022 | Jun 30, 2022 | 36.9% | +33.2 |
| Q1 FY2022 | Mar 31, 2022 | 36.3% | −1.5 |
| Q4 FY2021 | Dec 31, 2021 | 37.2% | +0.0 |
| Q3 FY2021 | Sep 30, 2021 | 42.9% | −0.5 |
| Q2 FY2021 | Jun 30, 2021 | 3.7% | −51.2 |
| Q1 FY2021 | Mar 31, 2021 | 37.9% | −1.9 |
| Q4 FY2020 | Dec 31, 2020 | 37.1% | −4.2 |
| Q3 FY2020 | Sep 30, 2020 | 43.4% | +37.3 |
| Q2 FY2020 | Jun 30, 2020 | 54.9% | +26.5 |
| Q1 FY2020 | Mar 31, 2020 | 39.8% | +8.5 |
| Q4 FY2019 | Dec 31, 2019 | 41.3% | −136.9 |
| Q3 FY2019 | Sep 30, 2019 | 6.1% | −10.4 |
| Q2 FY2019 | Jun 30, 2019 | 28.4% | +0.8 |
| Q1 FY2019 | Mar 31, 2019 | 31.3% | −1.5 |
| Q4 FY2018 | Dec 31, 2018 | 178.2% | +162.7 |
| Q3 FY2018 | Sep 30, 2018 | 16.4% | +34.2 |
| Q2 FY2018 | Jun 30, 2018 | 27.6% | +24.3 |
| Q1 FY2018 | Mar 31, 2018 | 32.8% | −1.9 |
| Q4 FY2017 | Dec 31, 2017 | 15.5% | +8.3 |
| Q3 FY2017 | Sep 30, 2017 | -17.8% | −8.4 |
| Q2 FY2017 | Jun 30, 2017 | 3.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 34.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 7.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -9.4% | – |
See a number that looks wrong?